Health Highlights: June 28, 2018

Here are some of the latest developments in health and medical news, compiled by the editors of HealthDay:

New drug could save many new mothers and babies: WHO

A new and sustainable drug Heat Resistant According to the World Health Organization, preventing potentially lethal bleeding in postpartum women could "revolutionize the ability" to save the lives of many new mothers and new babies.

The drug, called thermostable carbetocin, remains effective for 1000 days and can withstand extreme heat. Hot, humid conditions in many countries can reduce the effectiveness of existing drugs, BBC News reported

Each year, about 70,000 women die worldwide due to severe bleeding after Delivery, which also increases the risk of babies. to die in their first month of life. Currently, the WHO recommends to offer an injection of oxytocin to all women who give birth badlly

but oxytocin must be kept at low temperature, which does not occur. may not be possible in some countries

. Nineteen countries found that thermostable injections of carbetocin or oxytocin immediately after birth were equally effective in preventing excessive bleeding, BBC News reported.

The results were published in the New England Journal of Medicine

The development of the new drug is "very good news for the millions of women giving birth in parts of the world without access to reliable refrigeration, "said WHO expert Metin Gulmezoglu, BBC News

Thermostable carbetocin may be available in some countries as early as next year, according to WHO experts.